This is because the definitively treated women still have thyroid-stimulating antibodies that cross the placenta
and could affect the fetus but they have no concurrent treatment with thioamide, a drug that also crosses the placenta. Furthermore, we tend to forget these women had Graves’ disease because they are on thyroid replacement and, in our minds, they are labeled as having hypothyroidism